Sanofi, GSK get approval for Phase 3 COVID-19 vaccine trial in India
In a two-stage approach, the study will initially investigate the efficacy of a vaccine formulation targeting the original virus…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
neutralising antibody
COVAXIN is well tolerated with no serious adverse events in Phase I trials
The trial was conducted on volunteers from diverse geographic locations and socioeconomic conditions, enrolling 375 participants…
Sorrento gets US FDA nod for Phase 1 clinical trial of neutralising antibody in COVID-19 patients
Sorrento had earlier informed that COVI-GUARD (STI-1499) demonstrated 100 per cent in vitro neutralizing effect against SARS-CoV-2…